Key result
Combined oncologic treatment and specific pulmonary hypertension therapy led to complete remission of tumoural pulmonary hypertension at rest after 10 months in a 37-year-old woman.
Case Report (n=1)
A multidisciplinary approach combining oncologic and specific PH therapy can lead to complete remission of tumoural pulmonary hypertension.
May support combined therapy for tumoural PH remission; hypothesis-generating and requires prospective validation.
Background: Pulmonary hypertension (PH) is defined as a progressive disease that leads to right heart failure and death if untreated. This case report presents a young woman with reversible precapillary PH in the setting of a gastric cancer. Case summary: A 37-year-old woman presented with exertional dyspnoea and syncope. The transthoracic echocardiographic findings were consistent with a cor pulmonale. Right heart catheterization (RHC) proved a precapillary PH. Specific PH therapy with macitentan and tadalafil was initiated. Shortly thereafter, a gastric carcinoma was diagnosed, and oncologic treatment with neoadjuvant chemotherapy and subsequent gastrectomy was promptly initiated. Retrospectively, we considered a pulmonary tumour thrombotic microangiopathy the most probable cause of PH. Follow-up after successful oncologic treatment and cumulative 10 months of specific PH medication showed an excellent clinical response with complete remission of PH confirmed by RHC at rest. Discussion: studies have documented tumoural emboli in pulmonary microcirculation in ∼26% of patients with a solid tumour, markedly associated with adenocarcinoma. Prompt initiation of cancer treatment on tumoural PH is essential. To our knowledge, this report documents the first full recovery of tumoural PH at rest after successful cancer treatment and temporary specific PH medication. We therefore conclude that a multidisciplinary approach with an initially combined oncologic and PH therapy may be most beneficial with the potential of complete remission of PH.
No takes yet. Share an insight, caveat, or question.
Aeberhard et al. (2023) conducted a case report in Pulmonary hypertension in the setting of gastric cancer (n=1). Macitentan, tadalafil, and oncologic treatment (neoadjuvant chemotherapy and gastrectomy) was evaluated on Clinical response and remission of pulmonary hypertension. Combined oncologic treatment and specific pulmonary hypertension therapy led to complete remission of tumoural pulmonary hypertension at rest after 10 months in a 37-year-old woman.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: